- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech High Insider Buying
Hong Kong Pharmaceuticals & Biotech High Insider Buying
Results
10
10 companies
Grand Pharmaceutical Group
Market Cap: HK$22.2b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$6.33
7D
3.3%
1Y
55.5%
SSY Group
Market Cap: HK$10.0b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.40
7D
-1.4%
1Y
-31.0%
Ascletis Pharma
Market Cap: HK$6.3b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$6.50
7D
-13.6%
1Y
381.5%
HBM Holdings
Market Cap: HK$5.5b
A clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas.
2142
HK$7.55
7D
-12.0%
1Y
472.0%
Abbisko Cayman
Market Cap: HK$4.9b
Engages in the discovering and developing small molecule oncology therapies in China.
2256
HK$7.83
7D
-8.1%
1Y
171.9%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$2.7b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$6.59
7D
16.4%
1Y
-55.0%
Brii Biosciences
Market Cap: HK$1.4b
Engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.93
7D
-19.6%
1Y
103.2%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$777.2m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.90
7D
-2.2%
1Y
-22.4%
Kintor Pharmaceutical
Market Cap: HK$571.5m
A clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications with the unmet medical needs in the People’s Republic of China.
9939
HK$1.32
7D
-1.5%
1Y
51.7%
China NT Pharma Group
Market Cap: HK$167.2m
Engages in the investment, research and development, manufacturing, sales, and distribution of pharmaceutical products in the People’s Republic of China.
1011
HK$0.25
7D
3.3%
1Y
7.8%